Manila Times Business
Ambros Therapeutics Appoints Cris Calsada as Chief Financial Officer and Claire Padgett, Ph.D., as SVP of Clinical Operations and Program Management
IRVINE, Calif., June 11, 2026 (GLOBE NEWSWIRE) -- Ambros Therapeutics, Inc., today announced the appointment of Cris Calsada as Chief Financial Officer (CFO) and Claire Padgett, Ph.D., as Senior Vice President (SVP) of Clinical Operations and Program Management. Ms. Calsada will oversee the company’s finance organization, including financial strategy, capital planning, and investor relations. Dr. Padgett will oversee clinical operations and program management, including the pivotal CRPS-RISE Pha
This is an excerpt. Read the full article at the original source:
Source: manilatimes.net
Read Full Article on manilatimes.net →More from Manila Times Business
Manganese X Energy to Present at the June 16 Energy & Precious Metals Virtual Investor Summit
1h ago
Energy & Precious Metals Virtual Investor Summit Agenda Announced for June 16th
1h ago
WatchMatic Highlights Market Trends Influencing Luxury Watch Investment Strategies
1h ago
Playboy to Present at Planet MicroCap Las Vegas 2026
1h ago